Details of Drug-Drug Interaction
| Drug General Information (ID: DDIH8X0JTE) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Lumateperone | Drug Info | Ioflupane I-123 | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Atypical Antipsychotics | Diagnostic Radiopharmaceuticals | |||||||
| Structure | |||||||||
| Mechanism of Lumateperone-Ioflupane I-123 Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Interference of cell/tissue uptake Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Lumateperone | Ioflupane I-123 | |||||||
| Mechanism | Interference with the diagnosis of Ioflupane I-123 | Ioflupane I-123 | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the distribution of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Clinicians using ioflupane I-123 should be aware of possible diagnostic interference by dopamine agonists and antagonists. | ||||||||

